Down-regulation of LATS1 expression due to its promoter hyper-methylation was also observed in breast cancer, colorectal cancer and astrocytoma (Takahashi et al., 2005; Jiang et al., 2006; Wierzbicki et al., 2013). This evidence concerns the gene LATS1 and breast cancer.